Mar 07, 2025 / 01:00PM GMT
Operator
Good day, and welcome to the bioMérieux's fourth-quarter sales and full-year 2024 results conference call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Aymeric Fichet. Please go ahead.
Aymeric Fichet - Biomerieux SA - Investor Relations
Thanks. So good afternoon, everyone, and thank you for joining us to review the bioMérieux 2024 financial performance. I'm on line with Pierre Boulud, CEO; together with Guillaume Bouhours, CFO.
Before handing the call over to Pierre and Guillaume, please note that this conference call will include forward-looking statements that may change or be modified due to uncertainties and risks related to the company's environment. Accordingly, we cannot give any assurance as to whether we will achieve these objectives. I also remind you that today's call is being recorded and that a replay will be available on our website.
I will now hand the call over to Pierre and then we will open the call to discussion and questions.
Pierre Boulud -
Full Year 2024 Biomerieux SA Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
